- Home
- BCTXW
as 07-26-2024 4:00pm EST
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.
| Founded: | N/A | Country: | Canada |
| Employees: | 12 | City: | WEST VANCOUVER |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | N/A |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | N/A | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BriaCell Therapeutics Corp. Warrant News
BCTXW Breaking Stock News: Dive into BCTXW Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 days ago
BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer
GlobeNewswire
2 months ago
BriaCell Presents Clinical Efficacy Data at ASCO 2024
MT Newswires
2 months ago
BriaCell Begins Patient Enrollment in First-in-Human Study of Bria-OTS in Advanced Metastatic Breast Cancer
GlobeNewswire
2 months ago
BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer
MT Newswires
2 months ago
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study
MT Newswires
2 months ago
BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments
GlobeNewswire
2 months ago
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study
GlobeNewswire
2 months ago
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
Compare BCTXW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BCTXW BriaCell Therapeutics Corp. Warrant - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.